NCT01800825View on ClinicalTrials.gov

Clindamycin to Reduce Preterm Birth in a Low Resource Setting

PHASE4CompletedINTERVENTIONAL
Enrollment

1,726

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

April 30, 2016

Conditions
PregnancyPrematurityPreterm BirthBacterial Vaginosis
Interventions
DRUG

Clindamycin

Clindamycin 300 mg Orally will be administered twice daily for a total of 5 days

DRUG

Placebo

This will be an identical placebo comparator made of starch.

Trial Locations (1)

Unknown

Jawaharlal Nehru Medical College, Belagavi

All Listed Sponsors
collaborator

Jawaharlal Nehru Medical College

OTHER

collaborator

Thrasher Research Fund

OTHER

lead

Christiana Care Health Services

OTHER

NCT01800825 - Clindamycin to Reduce Preterm Birth in a Low Resource Setting | Biotech Hunter | Biotech Hunter